Preparation and characterization of mucus-penetrating papain/poly(acrylic acid) nanoparticles for oral drug delivery applications
- 1.1k Downloads
Particle diffusion through the intestinal mucosal barrier is restricted by the viscoelastic and adhesive properties of the mucus gel layer, preventing their penetration to the underlying absorptive endothelial cells. To overcome this natural barrier, we developed nanoparticles which have a remarkable ability to cleave mucoglycoprotein substructures responsible for the structural and rheological properties of mucus. After rheological screening of various mucolytic proteases, nanoparticles composed of poly(acrylic acid) and papain were prepared and characterized regarding particle size and zeta potential. Analysis of nanoparticles showed mean diameters sub-200 nm (162.8–198.5 nm) and negative zeta potentials advancing the mobility in mucus gel. Using diffusion chamber studies and the rotating diffusion tubes method, we compared the transport rates of papain modified (PAPC) and unaltered poly(acrylic acid) (PAA) particles through freshly excised intestinal porcine mucus. Results of the diffusion assays demonstrated strongly enhanced permeation behavior of PAPC particles owing to local mucus disruption by papain. Improved transport rates, reduction in mucus viscosity and the retarded release of hydrophilic macromolecular compounds make proteolytic enzyme functionalized nanoparticles of substantial interest for improved targeted drug delivery at mucosal surfaces. Although cytotoxicity tests of the nanoparticles could not be performed, safety of papain and PAA was already verified making PAPC particles a promising candidate in the pharmaceutical field of research. The focus of the present study was the development of particles which penetrate the mucus barrier to approach the underlying epithelium. Improvements of particles that penetrate the mucus followed by cell uptake in this direction are ongoing.
KeywordsOral drug delivery Mucus barrier Mucus-penetrating particles Poly(acrylic acid) Papain
This study was supported by the European Commission (EC). ALEXANDER (Mucus Permeating Nanoparticulate Drug Delivery Systems) is an Integrated Project founded within the Seventh Framework Programme of the EC (Grant Agreement Number 280761).
- da Silva CR, Oliveira MBN, Motta ES, de Almeida GS, Varanda LL, de Padula M et al (2010) Genotoxic and cytotoxic safety evaluation of papain (Carica papaya L.) using in vitro assays. J Biomed Biotechnol. doi: 10.1155/2010/197898
- Dautzenberg H, Hartmann J, Grunewald S, Brand F (1996) Stoichiometry and structure of polyelectrolyte complex particles in diluted solutions, Berichte Der Bunsen-Gesellschaft-Physical Chemistry. Chem Phys 100:1024–1032Google Scholar
- Mitchel REJ, Chaiken IM, Smith EL (1970) Complete amino acid sequence of papain—additions and corrections. J Biol Chem 245(14):3485Google Scholar
- Nordman H, Davies JR, Herrmann A, Karlsson NG, Hansson GC, Carlstedt I (1997) Mucus glycoproteins from pig gastric mucose: identification of different mucin populations from the surface epithelium. Biochem J 326:903–910Google Scholar
- Schlamowitz M, Peterson LU (1959) Studies on the optimum pH for the action of pepsin on native and denaturated bovine serum albumin and bovine hemoglobin. J Biol Chem 234(12):3137–3145Google Scholar
- Spackman DH, Stein WH, Moore S (1960) Disulfide bonds of ribonuclease. J Biol Chem 235(3):648–659Google Scholar